The average length of stay (ALOS) for glomerular and renal tubulo-interstitial diseases varies significantly across countries, with South Korea at 8.4 days and Netherlands at 3.7 days as of 2023. A 0.48% increase was noted for South Korea, while the Netherlands saw a notable decrease of 3.84% year over year. Canada reported a 2.71% rise, contrasting with declines in Italy, Sweden, and Iceland. Over five years, ALOS trends indicate diverging practices, with differing approaches to managing these diseases contributing to variability.
Looking ahead, trends to watch include technological advancements in treatment leading to reduced inpatient stays and the refinement of outpatient renal care globally, potentially influencing the ALOS data in the future.
Top countries in Hospital Average Length of Stay for Glomerular and Renal Tubulo-Interstitial Diseases Cases by Country
| # | 8 Countries | Days | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 8.4 | 2023 | 0% | +0.48% | View data |
| 2 | 2 Estonia | 7.2 | 2023 | 0% | +0.57% | View data |
| 3 | 3 Chile | 6.6 | 2023 | 0% | 0% | View data |
| 4 | 4 Italy | 6.3 | 2023 | -1.56% | -0.31% | View data |
| 5 | 5 Canada | 5.6 | 2023 | +1.82% | +2.71% | View data |
| 6 | 6 Sweden | 4.2 | 2023 | 0% | -0.47% | View data |
| 7 | 7 Iceland | 3.8 | 2023 | 0% | -0.26% | View data |
| 8 | 8 Netherlands | 3.7 | 2023 | -2.63% | -3.84% | View data |
